je.st
news
U.S. Food and Drug Administration Approves POMALYST (pomalidomide)...
2013-02-09 07:14:10| Biotech - Topix.net
Celgene Corporation today announced the U.S. Food and Drug Administration has approved POMALYSTA brand therapy for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and bortezomib and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Tags: food
administration
drug
drug administration
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||